Illumina 4Q Earnings Beat Wall Street Targets

Illumina Inc. (ILMN) on Wednesday reported fourth-quarter earnings that topped Wall Street projections.
The San Diego-based genetics-technology company posted quarterly net income of $239 million, or $1.61 a share. On an adjusted basis, profit rose to $1.70 a share from $1.31 a share a year earlier.
Revenue rose to $953 million from $867 million a year earlier.
Analysts surveyed by FactSet expected $1.46 a share, or $1.58 a share as adjusted, on $942.4 million in revenue.
This year, Illumina expects to make $6.45 to $6.65 a share, or $6.80 to $7 a share as adjusted, with revenue increasing 9% to 11%. The guidance, the company said, doesn’t factor in any impact from the termination of the merger agreement with Pacific Biosciences of California Inc. Illumina was to pay Pacific Biosciences $98 million as a termination fee.
Analysts expect $6.73 a share, or $7.02 a share as adjusted, with revenue increasing about 11%.

https://www.marketscreener.com/ILLUMINA-INC-9659/news/Illumina-4Q-Earnings-Beat-Wall-Street-Targets-29909851/